Logo
P

Proneurotech, Inc

50 employees

ProNeurotech is a developer of neuroprotective drugs that prevent axon loss after acute injury or chronic degenerative disease.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Neurodegeneration
Chemistry
Neuroscience
Neuroprotection
Axon Degeneration
Neurodegenerative Disease
Neurobiology
Health Care

Date founded

2018

Funding rounds raised

P

Proneurotech, Inc raised undisclosed on February 1, 2018

Investors: The Column Group

FAQ